Bill > HB3686

This bill amends the Illinois Controlled Substances Act by adding gonadotropin-releasing hormone (GnRH) analogs to Schedule V controlled substances. Schedule V is the lowest classification of controlled substances, typically referring to medications with a low potential for abuse and important medical uses. Currently, the law lists specific narcotic drugs in limited quantities that are classified as Schedule V, such as small amounts of codeine, dihydrocodeine, and ethylmorphine, along with other specific compounds. The bill expands this list to explicitly include any compound containing GnRH analogs. GnRH analogs are medications that mimic or block the action of gonadotropin-releasing hormone, which is often used in treating conditions related to reproductive hormones, such as certain cancers, fertility treatments, or hormonal disorders. By adding these compounds to Schedule V, the bill ensures that such medications are subject to controlled substance regulations, which typically involve prescription requirements and tracking to prevent misuse.

https://www.ilga.gov/legislation/BillStatus.asp?DocNum=3686&GAID=18&DocTypeID=HB&SessionID=114&GA=104